CLINICAL COURSE AND TREATMENT CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE. UOC [Internet]. 2026 Apr. 18 [cited 2026 Sep. 12];(11). Available from: https://www.openconf.uz/conf/article/view/376